Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
sunitinib dasatinib
sunitinib
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
sunitinib n = 553
sunitinib n=553
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
prior sunitinib treatment
tidigare sunitinib-behandling
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
the active substance is sunitinib.
den aktiva substansen är sunitinib.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
sutent 25 mg hard capsules sunitinib
sutent 25 mg kapsel, hård sunitinib
Last Update: 2011-10-23
Usage Frequency: 5
Quality:
combination of bevacizumab and sunitinib malate
kombinationsbehandling med bevacizumab och sunitinibmalat
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
sutent 25 mg hard capsules sunitinib oral use
sutent 25 mg kapsel, hård sunitinib för oralt bruk
Last Update: 2012-04-11
Usage Frequency: 5
Quality:
food has no effect on the bioavailability of sunitinib.
föda har ingen effekt på sunitinibs biologiska tillgänglighet.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
of patients receiving sunitinib malate for cytokine-
blödningar uppträdde hos 26% av de patienter som behandlades med sunitinibmalat vid cytokin- refraktär mrcc.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
sunitinib was not clastogenic in rat bone marrow in vivo.
sunitinib var inte klastogent i benmärg hos råtta in vivo.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
medicinal products that may decrease sunitinib plasma concentrations
läkemedel som kan minska plasmakoncentrationerna av sunitinib
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
each capsule contains sunitinib malate equivalent to 25 mg.
varje kapsel innehåller sunitinibmalat motsvarande 25 mg sunitinib.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
sutent is a medicine containing the active substance sunitinib.
sutent är ett läkemedel som innehåller den aktiva substansen sunitinib.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
carcinogenicity carcinogenicity studies with sunitinib malate have not been performed.
karcinogenicitet inga karcinogenicitetsstudier har utförts med sunitinibmalat.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
if fistula formation occurs, sunitinib treatment should be interrupted.
behandling med sunitinib ska avbrytas om fistel bildas.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
each capsule contains sunitinib malate, equivalent to 25 mg of sunitinib.
varje kapsel innehåller sunitinibmalat motsvarande 25mg sunitinib.
Last Update: 2017-04-26
Usage Frequency: 16
Quality:
cases of impaired wound healing have been reported during sunitinib therapy.
fall av försämrad sårläkning har rapporterats under behandling med sunitinib.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
the active substance in sutent, sunitinib, is a protein kinase inhibitor.
den aktiva substansen i sutent, sunitinib, är en proteinkinashämmare.
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
sunitinib treatment may be associated with cholecystitis, including acalculous cholecystitis and emphysematous cholecystitis.
behandling med sunitinib kan vara förknippad med kolecystit, inklusive kolecystit utan gallsten och emfysematös kolecystit.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
each capsule contains sunitinib malate equivalent to 50 mg of sunitinib excipient(s):
hjälpämne:
Last Update: 2011-10-23
Usage Frequency: 2
Quality: